PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients (Q35813637)

10 August 2017

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients (English)

1 reference

10 August 2017

0 references

1 reference

1 reference

Jee-Fu Huang

8

0 references

author name string

Chung-Feng Huang

1

1 reference

10 August 2017

Jyh-Jou Chen

2

1 reference

10 August 2017

Ming-Lun Yeh

3

1 reference

10 August 2017

Ching-I Huang

4

1 reference

10 August 2017

Ming-Yen Hsieh

5

1 reference

10 August 2017

Hua-Ling Yang

6

1 reference

10 August 2017

Chia-Yen Dai

7

1 reference

10 August 2017

Zu-Yau Lin

9

1 reference

10 August 2017

Shinn-Cherng Chen

10

1 reference

10 August 2017

Wan-Long Chuang

11

1 reference

10 August 2017

Yao-Li Chen

12

1 reference

10 August 2017

Ming-Lung Yu

13

1 reference

10 August 2017

language of work or name

English

0 references

publication date

3 July 2015

1 reference

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

11901

1 reference

Creative Commons Attribution 4.0 International

10 August 2017

start time

3 July 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/srep11901

0 references

cites work

Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Hepatitis B virus infection and metabolic syndrome: fact or fiction?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Treatment predictors of a sustained virologic response in hepatitis B and C.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Classification of chronic viral hepatitis: a need for reassessment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490397

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26139292

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PNPLA3gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26139292

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26139292

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SREP11901

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

26139292

1 reference